Quent Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-183
| Closed | -$6.63K | – | 1019 |
|
|
2025
Q1 | $6.63K | Sell |
183
-14
| -7% | -$507 | ﹤0.01% | 969 |
|
|
2024
Q4 | $8.29K | Sell |
197
-29
| -13% | -$1.22K | ﹤0.01% | 963 |
|
|
2024
Q3 | $12.6K | Hold |
226
| – | – | ﹤0.01% | 974 |
|
|
2024
Q2 | $9.29K | Buy |
226
+14
| +7% | +$575 | ﹤0.01% | 1001 |
|
|
2024
Q1 | $9.9K | Buy |
212
+77
| +57% | +$3.6K | ﹤0.01% | 1021 |
|
|
2023
Q4 | $6.46K | Sell |
135
-54
| -29% | -$2.58K | ﹤0.01% | 1035 |
|
|
2023
Q3 | $6.74K | Sell |
189
-47
| -20% | -$1.68K | ﹤0.01% | 1003 |
|
|
2023
Q2 | $10.9K | Hold |
236
| – | – | ﹤0.01% | 919 |
|
|
2023
Q1 | $9.46K | Hold |
236
| – | – | ﹤0.01% | 930 |
|
|
2022
Q4 | $10.9K | Buy |
+236
| New | +$10.9K | ﹤0.01% | 880 |
|